Sulbatam-zidebactam A Promising Combination Against Carbapenem resistant Acinetobacter Baumannii(carb) Isolates

Human Fluids-Pathogen Interplay and its Impact on Cefidericol Susceptibility of Carbapenem-Resistant Acinetobacter Baumannii

Emergence of Kpc Variants in Ceftazidime-Avibactam Resistant Klebsiella Pneumoniae Isolates from Argentina: blaKPC-80, blaKPC-81, blaKPC-96 and blaKPC-97 ASM MICROBE 9-13/6/2022, Washington, DC

Validation Of The Avibactam Agar Tests (avitest) To Determine Aztreonam Plus Avibactam (atm-avi) Susceptibility For Carbapenemase Producing Enterobacterales (cpe) ASM MICROBE 9-13/6/2022, Washington, DC

Emergence during the COVID-19 pandemic of Klebsiella pneumoniae ST307 co-producing KPC-3 and NDM-1 carbapenemases ASM MICROBE 9-13/6/2022, Washington, DC

Emergence of KPC-31, a KPC-3 Variant Associated with Ceftazidime-Avibactam Resistance, in a ST235 Pseudomonas Aeruginosa Clinical Isolate from Argentina ASM MICROBE 9-13/6/2022, Washington, DC

Aztreonam-avibactam susceptibility testing for carbapenemase-producing Enterobacterales (CPE) in the National Reference Laboratory (NRL): 2019-2021 surveillance results. 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) -April 23-26 – Lisbon, Portugal.

Emergence of KPC variants from clinical origin associated with reduced susceptibility to ceftazidime- avibactam, including four novel blaKPC-2 variants. 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) -April 23-26 – Lisbon, Portugal.

Novel complex class 1 integron carrying qnrB10 and blaCTX-M-2 in a twin variable region 2 found in a clinical Citrobacter freundii from Argentina.